INVA
Innoviva Inc
Price:  
18.58 
USD
Volume:  
438,337.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

INVA EV/EBITDA

0.2%
Upside

As of 2024-12-14, the EV/EBITDA ratio of Innoviva Inc (INVA) is 6.05. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INVA's latest enterprise value is 1,350.29 mil USD. INVA's TTM EBITDA according to its financial statements is 223.19 mil USD. Dividing these 2 quantities gives us the above INVA EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 6.5x - 7.7x 7.0x
Forward P/E multiples 8.0x - 10.8x 10.0x
Fair Price 11.75 - 24.32 18.61
Upside -36.8% - 30.9% 0.2%
18.58 USD
Stock Price
18.61 USD
Fair Price

INVA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-12-13 6.05
2024-12-12 6.04
2024-12-11 6.13
2024-12-10 6.17
2024-12-09 6.22
2024-12-06 6.18
2024-12-05 6.15
2024-12-04 6.13
2024-12-03 6.17
2024-12-02 6.20
2024-11-29 6.17
2024-11-27 6.18
2024-11-26 6.21
2024-11-25 6.22
2024-11-22 6.21
2024-11-21 6.18
2024-11-20 6.21
2024-11-19 6.19
2024-11-18 6.15
2024-11-15 6.14
2024-11-14 6.24
2024-11-13 6.48
2024-11-12 6.54
2024-11-11 6.48
2024-11-08 6.50
2024-11-07 6.45
2024-11-06 6.43
2024-11-05 6.29
2024-11-04 6.27
2024-11-01 6.24
2024-10-31 6.32
2024-10-30 6.37
2024-10-29 6.42
2024-10-28 6.43
2024-10-25 6.38
2024-10-24 6.39
2024-10-23 6.40
2024-10-22 6.44
2024-10-21 6.41
2024-10-18 6.46
2024-10-17 6.50
2024-10-16 6.51
2024-10-15 6.41
2024-10-14 6.42
2024-10-11 6.39
2024-10-10 6.31
2024-10-09 6.35
2024-10-08 6.40
2024-10-07 6.38
2024-10-04 6.36